Galantamine
Trovati 7 articoli
- Efficacy and adverse effects of cholinesterase inhibitors and Namenda in vascular dementia
- A systematic review and meta-analysis evaluated the efficacy and safety of cholinesterase inhibitors and Memantine ( Ebixa, Namenda ) in vascular dementia. Three Donepezil ( Aricept ), two Galantamine ( Reminyl ), one Rivastigmine ( Exelon ), and two Memantine trials, comprising 3093 patients ... (Leggi Articolo)
- Reminyl appears to protect against nerve agents
- A study, led by researchers from the University of Maryland School of Medicine, found that Galantamine ( also known as Reminyl ), a medication used to treat Alzheimer's disease, can be used to protect people against the toxic effects of nerve agents. The findings, published in the Proceedings ... (Leggi Articolo)
- Reminyl appears to protect against nerve agents
- A study, led by researchers from the University of Maryland School of Medicine, found that Galantamine ( also known as Reminyl ), a medication used to treat Alzheimer's disease, can be used to protect people against the toxic effects of nerve agents. The findings, published in the Proceedings ... (Leggi Articolo)
- Dementia: NICE SCIE guideline to improve care
- The National Institute for Health and Clinical Excellence ( NICE ) and the Social Care Institute for Excellence ( SCIE ) have issued joint guidance on the treatment and care of people with dementia in health and social care. The guideline covers the identification, treatment and care of peop... (Leggi Articolo)
- Alzheimer's drugs: Aricept, Exelon and Razadyne offer modest improvements, equal effectiveness
- The Alzheimer's drugs Aricept ( Donepezil ), Razadyne ( Galantamine ) and Exelon ( Rivastigmine ) can lead to small improvements in mental functioning and the ability to carry out everyday activities in people with mild to moderate forms of the disease, according to a review of recent studies. ... (Leggi Articolo)
- NICE proposes to withdraw Alzheimer’s drugs from NHS
- The drugs Donepezil ( Aricept ), Rivastigmine ( Exelon ), Galantamine ( Remynil ), and Memantine ( Ebixa ) should no longer be prescribed on the National Health Service ( NHS ) to treat Alzheimer's disease according a new draft guidance from the National Institute for Clinical Excellence ( NICE )... (Leggi Articolo)
- Mild cognitive impairment: deaths of 13 patients taking Galantamine
- After the deaths of 13 patients taking Reminyl ( Galantamine ) during two investigational studies, drug's prescribing information has been updated. In two randomized, placebo-controlled trials of 2 years duration in subjects with mild cognitive impairment ( MCI ), a total of 13 subjects on R... (Leggi Articolo)
